Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nautilus Biotechnolgy, Inc.

0.7137
-0.0113-1.56%
Volume:204.99K
Turnover:146.31K
Market Cap:90.03M
PE:-1.31
High:0.7300
Open:0.7261
Low:0.7003
Close:0.7250
Loading ...

CFO and Treasurer Anna Mowry Reports Acquisition of Common Shares in Nautilus Biotechnology Inc

Reuters
·
03 Jun

Nautilus Biotechnology Inc. to Participate in Goldman Sachs 46th Annual Global Healthcare Conference

Reuters
·
27 May

Parag Mallick, Chief Scientist, Reports Acquisition of Common Shares in Nautilus Biotechnology Inc

Reuters
·
13 May

Nautilus Biotechnology Inc (NAUT) Q1 2025 Earnings Call Highlights: Strategic Cost Reductions ...

GuruFocus.com
·
30 Apr

Nautilus Biotechnology Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
29 Apr

BRIEF-Nautilus Biotechnology Q1 EPS USD -0.13

Reuters
·
29 Apr

Nautilus Biotechnology Reports First Quarter 2025 Financial Results

THOMSON REUTERS
·
29 Apr

Nautilus Biotechnology Q1 EPS USD -0.13

THOMSON REUTERS
·
29 Apr

Nautilus Biotechnology Q1 Net Income USD -16.613 Million

THOMSON REUTERS
·
29 Apr

Nautilus Biotechnology Reports First Quarter 2025 Financial Results

GlobeNewswire
·
29 Apr

Nautilus Biotechnology Q1 EPS $(0.13) Beats $(0.16) Estimate, Cash Balance Of $192.8M

Benzinga
·
29 Apr

BRIEF-Nautilus Biotechnology Posts Qtrly Loss Per Share $0.13

Reuters
·
29 Apr

Nautilus Biotechnology Inc: Qtrly Loss per Share $0.13

THOMSON REUTERS
·
29 Apr

Nautilus Biotechnology Inc Q1 Shr View $-0.15 -- Lseg Ibes Data

THOMSON REUTERS
·
29 Apr

We're Keeping An Eye On Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate

Simply Wall St.
·
31 Mar

Nautilus Biotechnology price target lowered to $2.50 from $4 at Guggenheim

TIPRANKS
·
28 Feb

Nautilus Biotechnology Inc (NAUT) Q4 2024 Earnings Call Highlights: Progress in Proteome ...

GuruFocus.com
·
28 Feb

TD Cowen Reaffirms Their Buy Rating on Nautilus Biotechnolgy (NAUT)

TIPRANKS
·
28 Feb

Nautilus Biotechnology Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

BRIEF-Nautilus Biotechnology Q4 EPS USD -0.14

Reuters
·
27 Feb